Biotech · Private company
BicycleTx Limited
Track this companyFree. Adds BicycleTx Limited to your Dealase workspace and tells you when its record changes.
Clinical trials66 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- AvelumabPhase 2 · Metastatic Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- BT5528Phase 2 · Advanced Solid Tumor Historically Known for High EphA2 ExpressionClinicalTrials.gov · fetched Nov 12, 2026
- BT7480Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BT8009Phase 2 · Urinary Bladder NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine + cisplatin Or carboplatinPhase 2 · Metastatic Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Advanced Solid Tumor Historically Known for High EphA2 ExpressionClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- nuzefatide pevedotin (BT5528)Phase 2 · Pancreatic Ductal Adenocarcinoma (PDAC)ClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Metastatic Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Urinary Bladder NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- Zelenectide pevedotinPhase 2 · Metastatic Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- Zelenectide pevedotin (BT8009)Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)PHASE2 · RECRUITING · started Mar 5, 2026ClinicalTrials.gov NCT07450859 · fetched Nov 12, 2026
- Study of Zelenectide Pevedotin in Participants With Advanced Breast CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 3, 2025ClinicalTrials.gov NCT06840483 · fetched Nov 12, 2026
- Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 24, 2024ClinicalTrials.gov NCT06225596 · fetched Nov 12, 2026
- Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 ExpressionPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 2, 2021ClinicalTrials.gov NCT05163041 · fetched Nov 12, 2026
- Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 17, 2020ClinicalTrials.gov NCT04561362 · fetched Nov 12, 2026
- Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 7, 2019ClinicalTrials.gov NCT04180371 · fetched Nov 12, 2026